Your browser doesn't support javascript.
loading
Comparison of New Glucose-Lowering Drugs on the Risk of Pancreatitis in Type 2 Diabetes: A Network Meta-Analysis.
Zhang, Xuexue; Wang, Miaoran; Wang, Xujie; Zhu, Zhengchuan; Zhang, Wantong; Zhou, Zhongyang; Tang, Wei; Li, Qiuyan.
Afiliação
  • Zhang X; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Department of Endocrinology, China Academy of Chinese Medical Sciences, Beijing, China.
  • Wang M; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Department of Endocrinology, China Academy of Chinese Medical Sciences, Beijing, China.
  • Wang X; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Department of Endocrinology, China Academy of Chinese Medical Sciences, Beijing, China.
  • Zhu Z; Peking University Traditional Chinese Medicine Clinical Medical School [Xi yuan], Beijing, China. Electronic address: zhuzhengchuan999@pku.edu.cn.
  • Zhang W; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Zhou Z; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Tang W; Department of Endocrinology, Beijing University of Chinese Medicine, Beijing, China.
  • Li Q; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: liqiuyan0928@163.com.
Endocr Pract ; 28(3): 333-341, 2022 Mar.
Article em En | MEDLINE | ID: mdl-34922031
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatite / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Endocr Pract Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatite / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Endocr Pract Ano de publicação: 2022 Tipo de documento: Article